Literature DB >> 22886855

Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells.

Abhijit S Dighe1, Scott Yang, Vedavathi Madhu, Gary Balian, Quanjun Cui.   

Abstract

The mesenchymal stromal cells (MSCs) are reported to be immunoprivileged and osteogenic. We hypothesized that the use of allogeneic MSCs for bone repair was possible if they displayed an ability to induce similar osteogenesis in syngeneic as well as in allogeneic hosts. To test this hypothesis we used a cloned bone marrow derived cell, termed D1, isolated from Balb/c mice. The D1 cells were subcutaneously injected in syngeneic Balb/c, allogeneic immunocompetent B6, allogeneic T-cell deficient NCr nude, and allogeneic B6 Pfp-/- Rag2-/- mice that lack matured T and B cells as well as NK-cell cytolytic functions. D1 cells formed ectopic bones only in syngeneic or allogeneic immunocompromised hosts but not in allogeneic B6 hosts. The lack of T cells alone in allogeneic NCr mice was sufficient to promote osteogenesis in allogeneic environment. We observed a significantly higher number of T cells, B cells, macrophages and significantly higher expression of interferon gamma (IFN-γ) in B6 allogeneic implants as compared to the syngeneic implants. These factors correlated with severe inhibition of expression of alkaline phosphatase, osteocalcin, and runx2 genes in the implants from B6 mice. Our data suggest that strategies to inhibit T cells and IFN-γ functions will be useful for bone repair mediated by allogeneic MSCs.
Copyright © 2012 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886855      PMCID: PMC3510319          DOI: 10.1002/jor.22212

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  36 in total

1.  Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells.

Authors:  Wei Zhang; Wei Ge; Changhong Li; Shengguo You; Lianming Liao; Qin Han; Weimin Deng; Robert C H Zhao
Journal:  Stem Cells Dev       Date:  2004-06       Impact factor: 3.272

Review 2.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

3.  Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization.

Authors:  D R Diduch; M R Coe; C Joyner; M E Owen; G Balian
Journal:  J Bone Joint Surg Am       Date:  1993-01       Impact factor: 5.284

4.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

5.  Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.

Authors:  William T Tse; John D Pendleton; Wendy M Beyer; Matthew C Egalka; Eva C Guinan
Journal:  Transplantation       Date:  2003-02-15       Impact factor: 4.939

6.  Interleukin 10 is a growth factor for a population of regulatory T cells.

Authors:  C Asseman; F Powrie
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

7.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

Authors:  Katarina Le Blanc; Charlotte Tammik; Kerstin Rosendahl; Eva Zetterberg; Olle Ringdén
Journal:  Exp Hematol       Date:  2003-10       Impact factor: 3.084

8.  Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect.

Authors:  Treena Livingston Arinzeh; Susan J Peter; Michael P Archambault; Christian van den Bos; Steve Gordon; Karl Kraus; Alan Smith; Sudha Kadiyala
Journal:  J Bone Joint Surg Am       Date:  2003-10       Impact factor: 5.284

9.  Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats.

Authors:  Hiroyuki Tsuchida; Junichi Hashimoto; Eric Crawford; Paul Manske; Jueren Lou
Journal:  J Orthop Res       Date:  2003-01       Impact factor: 3.494

10.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

Authors:  Mauro Krampera; Sarah Glennie; Julian Dyson; Diane Scott; Ruthline Laylor; Elizabeth Simpson; Francesco Dazzi
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

View more
  15 in total

1.  Xylan hemicellulose improves chitosan hydrogel for bone tissue regeneration.

Authors:  Joshua R Bush; Haixiang Liang; Molly Dickinson; Edward A Botchwey
Journal:  Polym Adv Technol       Date:  2016-02-02       Impact factor: 3.665

Review 2.  Inflammation, mesenchymal stem cells and bone regeneration.

Authors:  Hongrui Liu; Dongfang Li; Yi Zhang; Minqi Li
Journal:  Histochem Cell Biol       Date:  2018-02-12       Impact factor: 4.304

Review 3.  Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification.

Authors:  Koji Matsuo; Robert Dalton Chavez; Emilie Barruet; Edward C Hsiao
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

4.  IFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFκB signaling.

Authors:  Lei Wang; Yinghua Zhao; Yi Liu; Kentaro Akiyama; Chider Chen; Cunye Qu; Yan Jin; Songtao Shi
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

Review 5.  Trauma-induced heterotopic bone formation and the role of the immune system: A review.

Authors:  Casey T Kraft; Shailesh Agarwal; Kavitha Ranganathan; Victor W Wong; Shawn Loder; John Li; Matthew J Delano; Benjamin Levi
Journal:  J Trauma Acute Care Surg       Date:  2016-01       Impact factor: 3.313

Review 6.  Bone physiology as inspiration for tissue regenerative therapies.

Authors:  Diana Lopes; Cláudia Martins-Cruz; Mariana B Oliveira; João F Mano
Journal:  Biomaterials       Date:  2018-09-17       Impact factor: 12.479

7.  Early Immunomodulatory Effects of Implanted Human Perivascular Stromal Cells During Bone Formation.

Authors:  Carolyn A Meyers; Jiajia Xu; Lei Zhang; Greg Asatrian; Catherine Ding; Noah Yan; Kristen Broderick; Justin Sacks; Raghav Goyal; Xinli Zhang; Kang Ting; Bruno Péault; Chia Soo; Aaron W James
Journal:  Tissue Eng Part A       Date:  2017-08-15       Impact factor: 3.845

8.  Palovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-κB Signaling Pathway following Stimulation of the Inflammatory Microenvironment.

Authors:  Junchao Huang; Jialiang Lin; Congbin Li; Bo Tang; Haijun Xiao
Journal:  Stem Cells Int       Date:  2022-04-28       Impact factor: 5.131

Review 9.  Interactions between MSCs and immune cells: implications for bone healing.

Authors:  Tracy K Kovach; Abhijit S Dighe; Peter I Lobo; Quanjun Cui
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

10.  Regulation of osteogenesis via miR-101-3p in mesenchymal stem cells by human gingival fibroblasts.

Authors:  Eri Kaneda-Ikeda; Tomoyuki Iwata; Noriyoshi Mizuno; Takayoshi Nagahara; Mikihito Kajiya; Kazuhisa Ouhara; Minami Yoshioka; Shu Ishida; Hiroyuki Kawaguchi; Hidemi Kurihara
Journal:  J Bone Miner Metab       Date:  2020-01-23       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.